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Abstract The cDNA encoding a phosphorylation-dependent 
inhibitory protein of protein phosphatase-1 (PP1) was isolated 
from a porcine aorta library. The coding region represented the 
complete amino acid sequence of this protein comprised of a 
novel 147-residue polypeptide, which we termed CPI17, a 17-
kDa PKC-potentiated inhibitory protein of PP1. As well as the 
native CPI17 from porcine aorta, the recombinant protein 
completely suppressed the PP1 activity ( IC 5 0 =0 .18 nM) by 
the stoichiometric thiophosphorylation. The CPI17 mRNA is 
expressed in smooth muscle tissues such as aorta and bladder, 
whereas little expression was observed in heart, skeletal muscle, 
and non-muscle tissues. These results suggest a specific 
regulatory mechanism of the PP1 activity through CPI17 in 
smooth muscle. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The Ser/Thr phosphatase of type-1 (PP1) controls many 
cellular functions including muscle contraction, cell division, 
transcription and metabolisms by dephosphorylating various 
target proteins [1]. PP1 molecules consist of a 38-kDa catalytic 
subunit (PPlc) and various kinds of the non-catalytic regula-
tory subunits, in vivo. These regulatory subunits modulate the 
substrate specificity of P P l c and localize PP1 molecules to 
some targets in cells [2]. 
PP1 activity is also regulated by modulator proteins, and 
some of them have been cloned from mammalian tissues; 
these include inhibitor-1, inhibitor-2, DARPP32 , NIPP-1 , 
and the homolog of yeast sds22 [3-7]. Inhibitor-1 and 
D A R P P 3 2 are well characterized as phosphorylation-depend-
ent inhibitory proteins. On the basis of an immunological 
study, inhibitor-1 was shown to be distributed in various tis-
sues [8] and regulates metabolisms responding to hormonal 
signals [1]. On the other hand, D A R P P 3 2 was specifically 
seen in brain, suggesting to be involved in the dopamine-medi-
ated signal transduction in nerve systems [9,10]. Both inhib-
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itors were potentiated by the PKA 1 phosphorylation [1]. 
However, the inhibitory activity was blocked by the regula-
tory subunits bound to P P l c [11-13]. 
In our earlier work, we have isolated the inhibitory protein 
for PP1 from porcine aorta smooth muscle [14]. This inhib-
itory protein was potentiated by the P K C phosphorylation. It 
is noteworthy that the phosphorylated inhibitory protein 
could suppress the activity of the PP1 holoenzyme comprised 
of a non-catalytic 69-kDa subunit as well as that of PP lc . 
With regard to the potentiating kinase and the inhibitory 
activity to the holoenzyme, the inhibitory protein from aortic 
smooth muscle was clearly distinct from the well-known in-
hibitors[2]. N o w we have cloned and characterized the c D N A 
for this inhibitory protein from porcine aorta smooth muscle. 
The isolated c D N A encodes a novel 16.7-kDa protein, com-
pared with any known modulators of PP1 . Therefore, we have 
termed it CPU 7, a PKC-potentiated PP1 inhibitory protein of 
17 kDa. The expression of CPU 7 m R N A was specific to 
smooth muscle tissues. These findings indicate a characteristic 
regulatory system for PP1 activity in smooth muscle cell. 
2. Materials and methods 
2.1. Preparation of RNA and cDNA library of porcine aorta smooth 
muscle 
Total cellular RNA of porcine aorta smooth muscle was prepared 
using the guanidinium thiocyanate-acid phenol procedure [15]. Poly-
adenylated (poly(A)+) RNA was fractionated by oligo(dT) cellulose 
(NEB) chromatography. An oligo(dT)-primed cDNA library in XEx-
Cell vector was prepared from poly(A)~ RNA using the TimeSaver 
cDNA synthesis kit with Directional cloning toolbox (Pharmacia), 
and packaged using Gigapack II packaging extracts (Stratagene), as 
described by the manufacturers. 
2.2. Isolation of a porcine aorta CPI17 cDNA clone 
The specific cDNA fragment of CPU 7 of porcine aorta was sequen-
tially amplified by PCR method using Ex-taq polymerase (Takara). 
Nucleotide sequences of PCR products were determined by the di-
deoxy procedure using a Hitachi SQ5500 DNA-sequencer after sub-
cloning into pCRII vector using the Original TA cloning kit (Invitro-
gene). The degenerate primers A, B, and C were designed from the 
available partial amino acid sequence of CPI17 [14], whose nucleotide 
sequences were 5'-TGGAT(T/C/A)GA(T/C)GGI(C/A)GI(T/C)TI-
GA(A/G)GA-3', 5'-GA(A/G)GCIGA(T/C)ATGCCIGA(T/C)GA-3', 
and 5'-(T/C)TTIA(G/A)IA(G/A)ICC(T/C)TG(A/G/T)AT(T/C)TT-3', 
respectively. At the first step, PCR was performed with primer A 
and C. The oligo(dT)-primed single-strand cDNA was used as a tem-
plate, which was synthesized from total RNA of porcine aorta using 
the cDNA cycle kit (Invitrogene). The second PCR was carried out 
with the primer B and C using the first PCR product as a template. 
The nucleotide sequence of the 93-bp product from the second PCR 
was identical to those expected from the amino acid sequences. To 
determine the 5'-terminal nucleotide sequence of CPU7, the rapid 
amplification of cDNA 5'-end method was performed using Mara-
thon cDNA amplification kit (Clontech), with the CPI17-specific pri-
mer indicated by a dotted line in Fig. 1. The oligo(dT)-primed double-
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strand cDNA was used as a template. A 0.3-kbp product was identi-
fied to contain the 5'-terminal region of the cDNA encoding CPI17. 
In order to obtain the full-length cDNA, the porcine aorta cDNA 
library constructed in the XExCell vector was screened using this 
0.3-kbp fragment as a probe after 32P-labeling. Ten positive clones 
in 280000 plaque forming units (pfu) of the library were identified, 
and each of them was isolated through the secondary and tertiary 
screenings. The phagemid (pExCell) containing the insert encoding 
CPU 7 was excised in vivo from the phage DNA according to the 
instruction provided by the manufacturer. 
2.3. Bacterial expression and purification of hexahistidine-tagged 
CPU 7 (HtCPW) 
The DNA fragment corresponding to the coding region of CPU 7 
gene was amplified by PCR using the mutagenic primers, 5'-AGG-
ACCGccatggCAGCTCAGCGGCTGGGCAAGC-3', and 5'-CGGG-
gtcgacGTCAGGGCGGCGCGGTCCGGGCGC-3', in which the ini-
tiation and termination codons were indicated by underlines, and 
nucleotide sequence giving restriction sites for Ncol and Sail were 
shown by small letters. The isolated pExCell vector containing the 
full-length CPU 7 cDNA was used as a template. After confirming 
the nucleotide sequence of the PCR product subcloned into pCRII, 
the 0.45-kbp Ncol-SaK fragment was cloned into NcollSali site of 
pET30 plasmid (Novagene). The constructed plasmid, named 
pHtCPI17, encodes the 44-residues of tag sequence, containing a 
(His)e-segment at N-terminus, followed by the complete amino acid 
sequence (147 residues) of CPI17. E. coli strain BL21(DE3) was trans-
formed with pHtCPI17 and grown overnight at 37°C in 5 ml of LB 
medium (10 g of tryptone, 5 g of yeast extract, and 5 g of NaCl/1, pH 
7.0) containing 30 ug/ml kanamycin. The culture was inoculated to 1 1 
of the same medium. Transformed cells were grown to the absorbance 
at 600 nm of 0.6 at 37°C, and the expression of HtCPI17 was induced 
by addition of 0.1 mM isopropyl-l-thio-(3-D-galactopyranoside into 
the culture for 3 h at 37°C. The bacteria were collected by centrifu-
gation at 4500 Xg for 10 min, and the cell pellet was washed 3 times 
with 100 ml of 0.9% NaCl, 25 mM Tris-HCl, pH 7.5. The pellet was 
suspended on ice with 50 ml of buffer A (0.5 M NaCl, 20 mM po-
tassium phosphate, pH 7.0, 1 mM benzamidine) containing 10 mM 
imidazole-HCl, pH 7.0, and 0.1 mM phenylmethylsulfonyl fluoride. 
The cells were disrupted by twice passage through a French press. The 
lysate was heated at 90°C for 5 min. After cooling on ice, the heat-
treated lysate was mixed with 1:1000 volume of 0.1 M diisopropyl 
fluorophosphate, and then clarified by centrifugation at 22000Xg for 
20 min. HtCPI17 in the lysate was adsorbed to Ni2+-bound Chelating-
Sepharose fast flow (Pharmacia) column (<|> 1.5X5.7 cm), at 4°C. The 
column was successively washed with buffer A containing 10 mM and 
0.1 M imidazole-HCl, pH 7.0. The bound proteins were eluted by 
buffer A with 0.5 M imidazole-HCl, pH 7.0. HtCPI17 was further 
purified by the gel filtration using a Sephacryl S-200 HR column {if 
2.7X60 cm) equilibrated with buffer B (0.5 M NaCl, 0.5 mM EDTA, 
0.1% 2-mercaptoethanol (2-ME), 10 mM 3-(/V-morpholino)-propane-
sulfonic acid (MOPS)-NaOH, pH 7.0). After detection of proteins in 
each fraction by SDS-PAGE, the fractions containing the homogene-
ous HtCPI17 were pooled, and dialyzed against 0.4% ammonium 
bicarbonate, 0.1% 2-ME. The dialysate of purified HtCPI17 was 
lyophilized and stored at -20°C. More than 30 mg of HtCPI17 was 
routinely purified to homogeneity from 1 1 of the cell culture (data not 
shown). 
HtCPI17 was thiophosphorylated with 0.08 U/ml PKC in 50 mM 
MOPS-NaOH, pH 7.0, containing 10 mM MgCl2, 1 mM dithiothrei-
tol, 0.2 mM CaCl2, 20 ug/ml phosphatidylserine, 2 ug/ml 1,2-diolein, 
1 mM ATPyS at 30°C for 60 min. One unit of PKC was defined as 
1 nmol of phosphorylation per minute. The reaction was terminated 
by heating at 70°C for 20 min. After centrifugation, the tp-HtCPI17 
was purified by MonoS 5/5 column chromatography [14]. The stoi-
chiometric thiophosphorylation was confirmed by polyacrylamide gel 
electrophoresis in the presence of 8 M urea. 
2.4. Northern hybridization 
The formamide-denatured total cellular RNA samples (10 ug each) 
were separated by electrophoresis on 1.2% formaldehyde-agarose gel 
and transferred to a nylon membrane (Gene Screen; NEN) in 
10XSSC (1XSSC: 0.15 M NaCl, 15 mM sodium citrate, pH 7.0). 
Filters were prehybridized for 2 h at 42°C in 30% formamide, 5 X SSC, 
5XDenhardt's solution [15], 1% SDS, 0.1 mg/ml salmon sperm DNA, 
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0.05% sodium pyrophosphate, before hybridizing at 42°C overnight 
with 32P-labeled probe (4.1x10 s cpm/ug) in the same solution. The 
32P-labeled probe was prepared using the random primer DNA label-
ing kit (Takara) in the presence of [cx-32P]CTP with the 0.45-kbp 
EcoRl fragment of pCR-CPI17. After washing at 20°C for 5 min 
with 2XSSC, 0.1% SDS, 0.05% sodium pyrophosphate for 4 times, 
the blot was washed 4 times each for 30 min: twice at 42°C and then 
twice at 53°C, in 0.2 X SSC, 0.1% SDS, 0.05% sodium pyrophosphate. 
The blot was exposed to an imaging plate (Type BAS-III; Fujix), and 
the hybridized bands were visualized by BAS-2000 (Fujix). 
2.5. Others 
CPU 7 of porcine aorta smooth muscle was isolated as described 
previously [14], and thiophosphorylated as described above. The cat-
alytic subunits of PP1 (PPlc) and PP2A (PP2Ac) were purified from 
rabbit skeletal muscle as described by Cohen et al. [16], or Martin et 
al. [17]. Calcineurin (CaN; PP2B) was extracted from porcine brain 
and purified by DEAE-Cellulofine A500m column (Seikagaku Co.) 
and calmodulin (CaM)-conjugated Sepharose column chromatogra-
phy [18]. 20-kDa subunit of smooth muscle myosin (LC20) was pre-
pared from frozen chicken gizzard and phosphorylated in the presence 
of 0.1 mM [y-32P]ATP as described by Yoshida and Yagi [19]. Porcine 
brain PKC and chicken gizzard CaM were purified according to the 
method described by Kikkawa et al. [20] and Yoshida et al. [21], 
respectively. Bovine serum albumin (BSA) was purchased from Sigma. 
The protein phosphatase activity was measured by determining the 
released 32Pi from 32P-labeled p-LC20 (2 uM). Assays for PPlc and 
PP2Ac were performed at 25°C in 50 mM MOPS-NaOH, pH 7.0, 
containing 0.1 mM EGTA 1 mg/ml BSA, 1 mM dithiothreitol, 1 mM 
benzamidine, 0.02% Brij-35. For CaN activity, 0.2 mM CaCl2, 1 mM 
MnCi2, and 1 uM CaM was added to the condition described above. 
The reaction was initiated by the addition of phosphatases. Concen-
trations of phosphatases were given in the figure legend. One unit of 
phosphatase (U) was defined as 1.0 umol of dephosphorylation per 
minute. Protein concentration was determined by the improved meth-
od of Bradford [22,23] using BSA as standard. The values of molec-
ular mass for CPI17 and HtCPI17 were 16.7 and 21.5 kDa, respec-
tively. Polyacrylamide gel electrophoresis in the presence of urea was 
performed using the gel containing 8 M urea, 9% acrylamide, 0.3% 
/V,JV'-methylene bisacrylamide, 80 mM 2,6-lutidine, and 80 mM N-
((trishydroxylmethyl)methyl)-2-aminoethanesulfonic acid (TES). Elec-
trophoresis was from anode to cathode in the running buffer (40 mM 
2,6-lutidine, 40 mM TES). Unphosphorylated and (thio)phosphoryl-
ated (Ht)CPI17s were completely separated by this system (data not 
shown). 
3. Results 
3.1. cDNA clones of CPU 7 from porcine aorta smooth muscle 
Ten positive clones were isolated from the cDNA library of 
porcine aorta smooth muscle using the 278-bp nucleotide 
fragment produced by the 5'-RACE PCR as a probe (Section 
2.2.). One of the clones termed pai8 had the longest insert 
consisting of 637 bp. The 586-bp nucleotide sequence of 
pai8 excluding a 51-bp polyadenylated sequence at a 3'-end 
is shown in Fig. 1. Sequences from other clones were identical 
to those of pai8 at corresponding regions (data not shown). 
The homology search for this sequence in GenBank and 
EMBL databases did not detect significant similarities to 
any characterized genes. However, the search found out 
near identical segments ( > 85% identical) in the expressed 
sequence tags (EST) database [24] from human fetal heart, 
lung, brain and uterus, and senescent fibroblast, and from 
mouse placenta and embryo. 
The sequence around the first ATG from 5'-end is conform-
able to the initiation signal for translation in vertebrates as 
described by Kozak [25]. As shown in Fig. 1, the amino acid 
sequence of 147 residues was deduced from the first ATG (23-
25) to TGA (464-466), with a calculated molecular mass of 
16672 Da. All of amino acid sequences determined from pep-
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540 
586 
Fig. 1. Complementary DNA and predicted protein sequence of the PKC-potentiated PPl inhibitory protein of porcine aorta smooth muscle. 
The left and right numbers indicate the position of amino acid and nucleotide, respectively. The dotted line indicates the position of an anti-
sense primer used for RACE PCR. The amino acid sequence determined from protein sequencing are indicated by capital letters. The underline 
marks the TGA stop codon. The threonine at position 38 is the phosphorylation site, and indicated by a double underline [14]. 
tide fragments of CPU 7 protein were identical to the sequence 
deduced from cDNA, and indicated by capital letters. The 
residue at position 38 is a phosphorylatable threonine neces-
sary to the potentiation of CPI17 [14]. CPI17 is basic (theo-
retical p /= 10.34), so the molecular mass of CPI17 has been 
overestimated by SDS-PAGE as 20 kDa [14]. The homology 
search using FASTA program against non-redundant protein 
sequence database libraries found out a polypeptide which has 
been termed phospholipase C neighboring gene (PNG) prod-
uct [26]. The PNG product was 44.9% identical to CPI17 at 
positions 7-120, when were permitted four insertions (data 
not shown). The amino acid sequence of CPU7 was distinct 
from those of other proteins in databases including any 
known modulator proteins and subunits of PPl. 
3.2. Characterization of gene product from CPI17 cDNA 
In order to determine whether the isolated gene product 
acts as an inhibitor of PPl, we expressed the recombinant 
CPU 7 as a fusion protein (HtCPI17) as described in Section 
2.3. HtCPI17 was phosphorylated or thiophosphorylated by 
PKC stoichiometrically, similarly to the native CPU 7 from 
porcine aorta [14]. 
The effect of HtCPI17 on phosphatase activities was shown 
in Fig. 2. The PPlc activity was inhibited by the thiophos-
phorylated HtCPI17 as indicated by closed circles with an 
IC50 of 0.18 nM. The inhibition reached to the maximum at 
10 nM tp-HtCPI17, where the PPlc activity was completely 
suppressed. The inhibitory activity of tp-HtCPI17 was indis-
tinguishable from that of tp-CPI17 as indicated by crosses. 
With high concentration of CPU 7, which could not be ana-
lyzed in earlier work [14], it appeared that unphosphorylated 
HtCPI17 (u-HtCPI17) inhibited PPlc activity with IC50 of 1.3 
uM. The tp-HtCPI17 suppressed PP2Ac activity to 60% of the 
maximum at 1.8 uM, but was not effective to suppress CaN 
activity. Any decreases in activities of PP2Ac and CaN were 
not observed in the presence of 4.6 |a,M u-HtCPI17 (data not 
shown). 
3.3. Expression of CPU 7 mRNA 
As shown in Fig. 3, the northern hybridization analysis 
revealed a 0.7-kb CPI17 mRNA in 10 |xg of total cellular 
RNA of porcine aorta and bladder smooth muscle. The size 
was consistent to that of the cDNA clone pai8 (Fig. 1). A 
weak signal of 0.7 kb was also detected in the total RNA 
fractions of brain. In skeletal and cardiac muscle, and liver, 
any specific signals were scarcely found (Fig. 3). A 0.7-kb 
mRNA of CPU 7 was also present in the extracts from rabbit 
10-12 10-11 10-10 10-9 10-" 1 0 - ' 10-« 10-5 
[ HtCPI17 ] (M) 
Fig. 2. Inhibition of protein phosphatases by the recombinant 
CPU7. PPlc («,0,X), PP2Ac (■), and CaN (A) were added in the 
assay mixtures to 86, 74 and 126 |xU/ml, respectively. The results 
from thiophosphorylated and unphosphorylated HtCPI17 were indi-
cated by closed and open symbols, respectively. The cross indicated 
the result of thiophosphorylated native CPU 7. Other conditions 
were described in Section 2. 
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Fig. 3. Northern hybridization analysis of various tissues from pig. 
Total cellular RNA (10 ug) was loaded on 1.2% formaldehyde-agar-
ose gels. The size indicated at the left side was determined using an 
RNA size marker (NEB). The blot was hybridized with 32P-labeled 
cDNA corresponding to CPU 7 coding region. 
aorta and brain, but any positive bands could not be detected 
from rabbit skeletal and cardiac muscle, and kidney (data not 
shown). 
4. Discussion 
We have previously purified a phosphorylation-dependent 
inhibitory protein of PP1 (CPU 7) with molecular mass of 20 
kDa from porcine aorta smooth muscle [14]. On the basis of 
the available partial amino acid sequence of the protein, we 
isolated here a cDNA clone encoding a 16.7-kDa polypeptide 
from a porcine aorta cDNA library. The amino acid sequence 
deduced from this clone was consistent with those of peptide 
fragments derived from CPU 7 protein, indicating that the 
gene product of this clone is CPU 7. 
The thiophosphorylated recombinant CPU 7 fused with the 
tag sequence suppressed the PPlc activity completely. PP2Ac 
and CaN activities were not significantly inhibited by the re-
combinant protein. Therefore, CPU 7 is defined as an inhib-
itory protein specific for PP1. The complete amino acid se-
quence of CPU 7 is novel compared with those of any known 
modulator proteins and subunits of PP1. As shown in our 
earlier work, phosphorylated CPU 7 could inhibit the holoen-
zyme containing non-catalytic subunit as well as PPlc, com-
pletely and rapidly [14]. It had been shown that the well-
known inhibitory proteins of PP1, inhibitor-1 and inhibitor-
2 had less effect on PP1 holoenzymes [11-13]. It is expected 
that the primary structure of CPU 7 responsible for binding to 
PP1 molecule is distinguishable from those of other inhibitory 
proteins. 
With use of the recombinant CPU 7 protein, the unphos-
phorylated CPI17 also inhibited the PPlc activity with IC50 of 
1.3 uM, a value over 7000-fold higher than that of the thio-
phosphorylated form. The result suggests CPU 7 is a potent 
inhibitor for PP1 even in the unphosphorylated form. The 
phosphorylation of the threonine at position 38 of CPU 7 
increases the affinity for PP1. It has been previously reported 
that DARPP32, which is the well-known phosphorylation-de-
pendent inhibitor, also could suppress the PPlc activity, in the 
unphosphorylated form [27]. The phosphorylation of 
DARPP32 induced about 2000-fold decrease in the IC50 for 
PPlc inhibition. On the basis of analysis using analog pep-
tides, residues 9-14 of DARPP32 were defined as the inhib-
itory domain [28]. Fig. 4 shows the N-terminal region of 
DARPP32 and inhibitor-1, containing two sites critical for 
the inhibition. The residues 8-14 (indicated by the box line) 
and residues around phosphorylation site (Thr-34, indicated 
by the black box) of DARPP32 are highly conserved in the 
corresponding region of inhibitor-1. The sequence of CPU 7 is 
distinct from these inhibitors even in the inhibitory domain 
(Fig. 4). However, in the alignment of the two sequences at 
Thr-38 of CPU 7 and Thr-34 of DARPP32, three residues, 
KIQ, in the inhibitory domain of DARPP32 are homologous 
to corresponding three residues, KLQ, of CPU 7. It is possible 
that the KLQ sequence shares a part of the inhibitory domain 
of CPU 7. Although the C-terminal residues adjacent to KIQ 
of DARPP32 are hydrophobic, the corresponding residues of 
CPU 7 are not. Such variant residues in CPU 7 may give its 
conspicuous character as the potent inhibitor against PP1 hol-
oenzyme. 
Molecular cloning of CPU 7 also confirmed that the expres-
sion of CPU 7 mRNA is specific to smooth muscle tissues such 
as aorta and bladder. The specific PP1 holoenzyme (smPPlM) 
exists to control the extent of phosphorylation of myosin in 
smooth muscle [13,29]. While the 110-kDa subunit of 
smPPlM is widely expressed [30], smPPlM is a candidate 
for the target of CPU 7 in smooth muscle. The present data 
clearly indicated the novel mechanism for PP1 regulation 
through CPU 7 in smooth muscle cells. This finding will give 
a clue to understand the signal transduction involving the 
specific PP1 for smooth muscle functions. 
In contrast to the northern analysis, some homologous 
cDNAs to CPU 7 were found out in EST database of non-
muscle tissues. These genes possibly encode non-muscle ho-
mologs of CPU 7. Another homolog detected in protein data-
bases, which has been characterized as a phospholipase C 
neighboring gene (PNG) product. The PNG was shown to 
be widely distributed and the function of this gene product 
CPI17 
DARPP32 
Inhibitor-1 
MAAQRLGKRVLSKLQSPSRARGPGGSPGGL-QKRHARV0VKYDRREL 
± * * * * H 
MDPKDRKKIQFSVPAPPSQLDPRQVEMIRRRRPRPAMLFRLS 
MEODNSPRIKIOFTVPILLEPHLDPEAAEOIRRRRPHPATLVLTS 
Fig. 4. Comparison of the amino acid sequence of CPU 7 to the N-terminal regions of DARPP32 and inhibitor-1. Identities are marked by as-
terisks, and an insertion was indicated by a dash. The amino acid sequences of bovine brain DARPP32 and rat skeletal muscle inhibitor-1 are 
from [5] and [3], respectively. The inhibitory domain [28] for DARPP32 and the corresponding region of inhibitor-1 is indicated by a box line. 
The phosphorylation residue required for the potentiation is indicated by a black box. 
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remains unknown [26]. It is interesting that the conserved 
region of PNG to CPU 7 involves the threonine corresponding 
to Thr-38 of CPI17. Thus, we expect that the PKC-potenti-
ated inhibitory proteins like CPU 7 may control the PP1-medi-
ated cellular events in various tissues. 
References 
[1] Cohen, P. (1989) Annu. Rev. Biochem. 58, 453-508. 
[2] Hubbard, M.J. and Cohen, P. (1993) Trends Biochem. Sci. 18, 
172-177. 
[3] Elbrecht, A., DiRenzo, J., Smith, R.G. and Shenolikar, S. (1990) 
J. Biol. Chem. 265, 13415-13418. 
[4] Park, I.-K., Roach, P., Bondor, J., Fox, S.P. and DePaoli-Roach, 
A.A. (1994) J. Biol. Chem. 269, 944-954. 
[5] Kurihara, T., Lewis, R.M., Eisler, J. and Greengard, P. (1988) 
J. Neurosci. 8, 508-517. 
[6] Van Eynde, A., Wera, S., Beullens, M., Torrekens, S., Van 
Leuven, F., Stalmans, W. and Bollen, M. (1995) J. Biol. Chem. 
270, 28068-28074. 
[7] Renouf, S., Beullens, M., Wera, S., Van Eynde, A., Sikela, J., 
Stalmans, W. and Bollen, M. (1995) FEBS Lett. 375, 75-78. 
[8] MacDougall, L.K., Campbell, D.G., Hubbard, M.J. and Cohen, 
P. (1989) Biochim. Biophys. Acta 1010, 218-226. 
[9] Hemmings Jr., H.C., Girault, J.-A., Nairn, A.C., Bertuzzi, G. 
and Greengard, P. (1992) J. Neurochem. 59, 1053-1061. 
[10] Hemmings Jr., H.C. and Nairn, A.C. (1991) Adv. Prot. Phos-
phatases 6, 525-537. 
[11] Stralfors, P., Hiraga, A. and Cohen, P. (1985) Eur. J. Biochem. 
149, 295-303. 
[12] Dent, P., Macdougall, L.K., Mackintosh, C , Campbell, D.G. 
and Cohen, P. (1992) Eur. J. Biochem. 210, 1037-1044. 
[13] Alessi, D., Macdougall, L.K., Sola, M.M., Ikebe, M. and Cohen, 
P. (1992) Eur. J. Biochem. 210, 1023-1035. 
[14] Eto, M., Ohmori, T., Suzuki, M., Furuya, K. and Morita, F. 
(1995) J. Biochem. 118, 1104-1107. 
M. Eto et al./FEBS Letters 410 (1997) 356-360 
[15] Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) Molecular 
Cloning: A Laboratory Manual, 2nd EDN., Cold Spring Harbor 
Labratory, Cold Spring Harbor, NY. 
[16] Cohen, P., Alemany, S., Hemmings, B.A., Resink, T.J., Stralfors, 
P. and Tung, H.Y.L. (1988) Methods Enzymol. 159, 390^108. 
[17] Martin, B.L., Shriner, C.L. and Brautigan, D.L. (1994) Prot. 
Express. Purif. 5, 211-217. 
[18] Moriya, M., Fujinaga, K., Yazawa, M. and Katagiri, C. (1995) 
Cell Tiss. Res. 281, 273-281. 
[19] Yoshida, M. and Yagi, K. (1988) J. Biochem. 103, 380-385. 
[20] Kikkawa, U., Go, M., Koumoto, J. and Nishizuka, Y. (1986) 
Biochem. Biophys. Res. Commun. 135, 636-643. 
[21] Yoshida, M., Minowa, O. and Yagi, K. (1983) J. Biochem. 94, 
1925-1933. 
[22] Bradford, M.M. (1976) Anal. Biochem. 72, 248-254. 
[23] Friedenauer, S. and Berlet, H.H. (1989) Anal. Biochem. 178, 
263-268. 
[24] Adams, M.D., Kelley, J.M., Gocayne, J.D., Dubnick, M., Poly-
meropoulos, M.H., Xiao, H., Merril, C.R., Wu, A., Olde, B., 
Moreno, R.F., Kerlavage, A.R., McCombie, W.R. and Venter, 
J.C. (1991) Science 252, 1651-1656. 
[25] Kozak, M. (1987) Nucl. Acids Res. 15, 8125-8148. 
[26] Lagercrantz, J., Carson, E., Larsson, C , Nordenskjold, M. and 
Weber, G. (1996) Genomics 31, 380-384. 
[27] Desdouits, F., Cheetham, J.J., Huang, H.-B., Kwon, Y.-G., da 
Cruz e Silva, E.F., Denefle, P., Ehrlich, M.E., Nairn, A.C, 
Greengard, P. and Girault, J.-A. (1995) Biochem. Biophys. Res. 
Commun. 206, 652-658. 
[28] Hemmings Jr., H.C, Nairn, A.C, Elliott, J.I. and Greengard, P. 
(1990) J. Biol. Chem. 265, 20369-20375. 
[29] Shirazi, A., Iizuka, K., Fadden, P., Mosse, C , Somlyo, A.P., 
Somlyo, A.V. and Haystead, T.A.J. (1994) J. Biol. Chem. 269, 
31598-31606. 
[30] Okubo, S., Ito, M., Takashiba, Y., Ichikawa, K., Miyahara, M., 
Shimizu, H., Konishi, T., Shima, H., Nagao, M., Hartshorne, 
D.J. and Nakao, T. (1994) Biochem. Biophys. Res. Commun. 
200, 429^134. 
